age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
67.06396
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 15,291
| 7,507.1133
| null | 18
|
hispanic
| 23
| 37
| 0.819946
| 0.706909
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 10
| 62
| 11.5
| 68
| 16
| 36.79688
| 392
| null | 0.399963
| 4.399414
| 133
| 7.339844
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 194
| 1
|
76.28497
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 0
| 12,633
| 6,874.457
| null | 12
|
white
| 19.5
| 39
| 0.830933
| 0.773926
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 10
| 58
| 13.099609
| 60
| 24
| 36.59375
| 285.6875
| 2.299805
| 0.599976
| 1.5
| 139
| 7.319336
| null | null | null | 3
| 3
|
adl>=4 (>=5 if sur)
| 3
| 1,335
| 1
|
95.58099
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 4
|
under $11k
| 26
| 27,548
| 17,302.7969
| null | 10.333328
|
black
| 24.898438
| 50
| 0.463989
| 0.344971
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 22
| 58
| 4
| 78
| 30
| 34.89844
| 416.625
| 2.099609
| 0.299988
| 1.399902
| 144
| 7.429688
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 23
| 1
|
60.79398
|
male
| 0
| 25
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 26,174
| 17,180.8281
| null | 12.333328
|
black
| 24.5
| 32
| 0.822998
| 0.711914
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 1
| 80
| 6.099609
| 100
| 25
| 35.59375
| null | null | null | 1.899902
| 149
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 323
| 1
|
52.28497
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 10,612
| 7,649.7734
| null | 21
|
white
| 21.597656
| 27
| 0.898926
| 0.830933
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 7
| 104
| 17.398438
| 101
| 28
| 36.29688
| 257.125
| null | null | 0.699951
| 138
| 7.389648
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 617
| 1
|
58.32199
|
female
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 75,398
| 51,512.75
| null | 15.666664
|
white
| 20.597656
| 22
| 0.814941
| 0.75293
| 27
| 0
| 0
|
no
| 0.6
| 0.45
|
dnr after sadm
| 4
| 55
| 10.5
| 58
| 24
| 38.79688
| null | null | null | 1.099854
| 133
| 7.369141
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 22
| 1
|
83.46899
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 9
| 7,015
| 4,895.7891
| null | 11
|
white
| 21
| 22
| 0.710938
| 0.55188
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 1
| 107
| 6.699219
| 60
| 25
| 35.59375
| 404.3125
| null | null | 0.599976
| 138
| 7.399414
| null | null | null | 1
| 0
|
adl>=4 (>=5 if sur)
| 0
| 76
| 1
|
65.46997
|
female
| 1
| 142
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$11-$25k
| 0
| 216,883
| 123,592.312
| null | 33.75
|
white
| 28.398438
| 28
| 0.733887
| 0.651978
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 115
| 61
| 17
| 128
| 10
| 36
| 132.5
| 2.299805
| 0.899902
| 1
| 136
| 7.419922
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 142
| 1
|
77.008
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 11,872
| 6,965.2148
| null | 9.5
|
white
| 18.296875
| 23
| 0.843994
| 0.743896
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 8
| 80
| 10.298828
| 80
| 20
| 35.59375
| 357.125
| null | null | 1.5
| 139
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,690
| 0
|
85.37195
|
male
| 1
| 9
|
Coma
|
Coma
| 1
| 16
|
$25-$50k
| 44
| 18,329
| 7,512.7578
| null | 31
|
white
| 31.097656
| 52
| 0.105988
| 0.064987
| 1
| 0
| 1
|
no
| 0.5
| 0.2
|
dnr after sadm
| 2
| 123
| 8.199219
| 136
| 34
| 38
| 84
| 3.399902
| 1
| 1.799805
| 143
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 4.395508
| 9
| 1
|
83.16199
|
male
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 15
| null | 0
| 18,052
| 12,468.0547
| null | 8.333328
|
white
| 18.5
| 33
| 0.628906
| 0.317993
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.3
|
dnr after sadm
| 1
| 123
| 6.5
| 110
| 20
| 36.39844
| 228
| null | null | 1.099854
| 136
| 7.459961
| null | null | null | 1
| null |
<2 mo. follow-up
| 1.1669
| 29
| 1
|
65.91595
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 14,437
| 9,101.7734
| null | 38
|
white
| 54.695313
| 89
| 0.071991
| 0.025997
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 3
| 30
| 13.699219
| 0
| 0
| 38.79688
| 255
| null | null | 6.299805
| 137
| 7.289062
| null | null | null | null | null |
<2 mo. follow-up
| 2.091797
| 4
| 1
|
79.22498
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
$11-$25k
| 0
| 12,608
| 8,627.8359
| null | 11.5
|
white
| 20.699219
| 25
| 0.805908
| 0.741943
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 9
| 103
| 5.299805
| 60
| 20
| 35.79688
| 328
| 2.5
| 0.599976
| 1.5
| 137
| 7.40918
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,453
| 1
|
78.09998
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 14
| null | 0
| 14,896
| 10,624.0078
| null | 8
|
white
| 21.597656
| 27
| 0.717896
| 0.56189
| 1
| 0
| 0
|
yes
| 0.7
| 0.2
|
no dnr
| 13
| 80
| 5.5
| 100
| 25
| 36.29688
| 147.5
| 3.899902
| null | 1.399902
| 140
| 7.339844
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 1,687
| 0
|
59.88797
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
| null | 0
| 18,408
| 9,522.8906
| null | 18
|
white
| 30.699219
| 50
| 0.653931
| 0.554932
| 1
| 0
| 0
|
yes
| 0.8
| 0.04
|
no dnr
| 13
| 50
| 24.199219
| 74
| 12
| 36.29688
| null | 3.399902
| 0.5
| 3.099609
| 143
| null | null | null | null | 1
| 1
|
SIP>=30
| 1
| 340
| 1
|
59.27197
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 9,120
| 6,131.0703
| null | 6
|
white
| 15.298828
| 26
| 0.91394
| 0.85498
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 9
| 73
| 7.899414
| 70
| 20
| 36.09375
| 304.75
| 3.699707
| 1.099854
| 1.399902
| 143
| 7.419922
| null | null | null | 2
| 1
|
SIP>=30
| 1
| 1,683
| 0
|
63.25299
|
male
| 0
| 3
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 4,324
| 2,529.5195
| null | 9
|
white
| 29.296875
| 24
| 0.582886
| 0.262939
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.2
|
no dnr
| 3
| 103
| 10.599609
| 100
| 20
| 36.69531
| null | 3.199707
| 6.399414
| 0.699951
| 131
| null | null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 43
| 1
|
69.125
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 6,270
| 4,137.7578
| null | 14
|
white
| 21.097656
| 29
| 0.836914
| 0.73291
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 6
| 113
| 6.5
| 70
| 20
| 36.69531
| 396
| null | null | 4
| 136
| 7.329102
| null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 765
| 1
|
71.461
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 23
|
$25-$50k
| 0
| 9,665
| 6,271.7461
| null | 13
|
white
| 21.398438
| 27
| 0.591919
| 0.272949
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 7
| 107
| 8.298828
| 108
| 32
| 37.89844
| null | 3.099609
| 0.5
| 1.099854
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 266
| 1
|
87.24194
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
|
under $11k
| 0
| 18,381
| 6,058.1445
| null | 27.5
|
white
| 29.199219
| 56
| 0.605957
| 0.5
| 1
| 0
| 1
|
no
| 0.5
| 0.4
|
dnr after sadm
| 2
| 47
| 9.599609
| 66
| 10
| 37.69531
| 220
| 2.699707
| 0.699951
| 4.299805
| 142
| 7.269531
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 8
| 1
|
57.79898
|
male
| 0
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 129,188
| 48,944.9688
| null | 33
|
white
| 33.09375
| 26
| 0.567993
| 0.455994
| 3
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 55
| 49
| 15.798828
| 50
| 10
| 38.09375
| 155
| null | 0.399963
| 0.599976
| 130
| 7.399414
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.171875
| 1,681
| 0
|
72.62695
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 15,794
| 7,943.2148
| null | 14.5
|
white
| 22.796875
| 34
| 0.787964
| 0.659912
| 1
| 0
| 0
|
no
| 0.95
| 0.7
|
dnr after sadm
| 6
| 130
| 11.199219
| 109
| 40
| 36.69531
| 416
| null | null | 1.299805
| 134
| 7.369141
| null | null | null | 1
| 0
|
SIP>=30
| 0
| 1,643
| 1
|
69.21594
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 5,314
| 3,484.1719
| null | 8
|
white
| 20.199219
| 45
| 0.846924
| 0.747925
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 73
| 7.199219
| 80
| 25
| 37.19531
| 248
| null | 0.699951
| 2.899902
| 137
| 7.459961
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 422
| 1
|
49.87299
|
female
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
| null | 0
| 35,115
| 16,667.8594
| null | 36
|
white
| 41.898438
| 38
| 0.091995
| 0.036995
| 10
| 0
| 0
|
metastatic
| 0.3
| 0.2
|
dnr after sadm
| 7
| 43
| 2.699707
| 128
| 32
| 35.89844
| 205
| 2.5
| 0.599976
| 0.599976
| 136
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.51416
| 8
| 1
|
81.19098
|
male
| 0
| 61
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 7
|
$25-$50k
| 0
| 68,286
| 44,503.1875
| null | 15.5
|
white
| 24.796875
| 48
| 0.730957
| 0.647949
| 1
| 1
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 61
| 57
| 7.099609
| 51
| 24
| 37.89844
| 496
| 2.5
| 0.399963
| 3.599609
| 150
| 7.459961
| null | null | null | 1
| null |
SIP>=30
| 1.1669
| 1,676
| 0
|
50.19598
|
female
| 0
| 23
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 2
|
>$50k
| 0
| 31,479
| 20,222.6562
| null | 11.666664
|
white
| 28.898438
| 33
| 0.698975
| 0.534912
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 23
| 103
| 12.199219
| 80
| 20
| 36.09375
| null | 3.699707
| 0.699951
| 3.799805
| 125
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,676
| 0
|
69.12299
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 10
| null | 0
| 53,798
| 40,329.6875
| null | 36
|
white
| 26.199219
| 48
| 0.719971
| 0.633911
| 4
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 8
| 110
| 6.699219
| 70
| 12
| 38.29688
| 107.14062
| null | null | 6.199219
| 142
| 7.429688
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 10
| 1
|
82.35699
|
female
| 0
| 241
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 209,565
| 143,218.5
| null | 11
|
black
| 17.898438
| 27
| 0.766968
| 0.692993
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 1
| 137
| 21.898438
| 100
| 20
| 37.79688
| 323.75
| 3.599609
| 1
| 1.199951
| 135
| 7.399414
| null | null | null | null | null | null | 3.057617
| 1,231
| 1
|
52.57797
|
female
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 11
|
under $11k
| 0
| 7,638
| 5,049.6445
| null | 4
|
white
| 15.898438
| 27
| 0.873901
| 0.790894
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 7
| 67
| 6.799805
| 70
| 15
| 37
| 180.9375
| 2.799805
| 0.799927
| 1.099854
| 138
| 7.379883
| null | null | null | 1
| null | null | 1.1669
| 118
| 1
|
71.79498
|
male
| 0
| 25
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 18
|
$11-$25k
| 0
| 46,839
| 22,876.9062
| null | 28
|
white
| 23.199219
| 13
| 0.787964
| 0.659912
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 10
| 61
| 11.199219
| 68
| 10
| 37.69531
| 152.5
| 3.199707
| 0.699951
| 0.699951
| 136
| 7.419922
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 97
| 1
|
38.66699
|
female
| 0
| 21
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 9
| null | 0
| 46,790
| 20,298.0625
| null | 41
|
black
| 43.796875
| 63
| 0.424988
| 0.224976
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 21
| 43
| 29.097656
| 43
| 8
| 35.59375
| 217
| 2.399902
| 11.099609
| 0.5
| 137
| 7.359375
| null | null | null | null | 0
| null | 0
| 1,670
| 0
|
77.85394
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 17
| null | 9
| 8,190
| 5,374.0156
| null | 11
|
white
| 15.599609
| 24
| 0.834961
| 0.72998
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 7
| 63
| 7.899414
| 80
| 20
| 36.69531
| 261.875
| null | null | 0.799927
| 133
| 7.369141
| null | null | null | null | null | null | 2.091309
| 902
| 1
|
70.45898
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
$25-$50k
| 0
| 21,065
| 11,537.9062
| null | 14.666664
|
white
| 16.5
| 36
| 0.878906
| 0.835938
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 14
| 61
| 8.898438
| 65
| 36
| 38.29688
| 256.625
| 3
| 1.199951
| 1.5
| 137
| 7.359375
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,669
| 0
|
77.435
|
male
| 1
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 5,085
| 3,324.0449
| null | 12
|
white
| 26.097656
| 39
| 0.691895
| 0.526978
| 1
| 0
| 1
|
no
| 0.5
| 0.25
|
dnr after sadm
| 1
| 77
| 7.599609
| 120
| 40
| 39.09375
| 140
| null | null | 0.899902
| 139
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 5.772461
| 4
| 1
|
83.30194
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 9
| 25,474
| 18,161.7188
| null | 33.5
|
white
| 25.398438
| 60
| 0.656982
| 0.55896
| 2
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 12
| 59
| 14.599609
| 160
| 24
| 38.5
| 256.625
| null | 0.699951
| 2.399902
| 141
| 7.369141
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 35
| 1
|
77.42896
|
male
| 1
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 93,900
| 58,769.0312
| null | 23.75
| null | 35.09375
| 55
| 0.376953
| 0.258972
| 32
| 1
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 32
| 49
| 16.398438
| 131
| 32
| 36.39844
| 187.75
| 2.099609
| 0.799927
| 1.299805
| 155
| 7.379883
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 39
| 1
|
90.57599
|
female
| 1
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 9,106
| 6,112.6406
| null | 14
|
white
| 20.796875
| 35
| 0.754883
| 0.612915
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
dnr after sadm
| 3
| 73
| 5.5
| 60
| 25
| 35.39844
| null | 3.699707
| null | 1.699951
| 142
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.70752
| 9
| 1
|
54.237
|
female
| 0
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 9
| 3,979
| 2,404.7246
| null | 6
|
white
| 23.296875
| 28
| 0.744995
| 0.5979
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 80
| 6.599609
| 80
| 20
| 36.39844
| 504.75
| 2.099609
| 6.5
| 0.799927
| 129
| 7.449219
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 722
| 1
|
83.10199
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
| null | 0
| 3,464
| 2,371.1113
| null | 2
|
white
| 19.199219
| 22
| 0.766968
| 0.629883
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 4
| 117
| 5
| 50
| 20
| 36.69531
| 336.625
| null | null | 1.699951
| 141
| 7.429688
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,663
| 0
|
66.92096
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 16
|
>$50k
| 0
| 13,139
| 6,770.543
| null | 16.5
|
white
| 30.097656
| 31
| 0.701904
| 0.539917
| 1
| 0
| 0
|
no
| 0.98
| 0.9
|
no dnr
| 8
| 56
| 6.599609
| 109
| 8
| 37.89844
| 180
| 2.399902
| null | 0.599976
| 141
| 7.40918
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,661
| 0
|
73.487
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 8,837
| 5,661.6797
| null | 7.5
|
black
| 19
| 14
| 0.769897
| 0.522949
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
dnr before sadm
| -1
| 109
| 9.5
| 72
| 20
| 36.09375
| null | 2.5
| 0.399963
| 1
| 134
| null | null | null | null | 4
| 2
|
<2 mo. follow-up
| 2
| 14
| 1
|
66.52399
|
female
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 26,499
| 10,231.5625
| null | 25
|
black
| 37.59375
| 56
| 0.248993
| 0.145996
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 1
| 49
| 11.798828
| 129
| 40
| 38.59375
| 175
| 4.099609
| 2.5
| 1.699951
| 147
| 7.479492
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.737793
| 230
| 1
|
41.12299
|
male
| 0
| 59
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 61
| 78,089
| 47,791.0625
| null | 16.5
|
black
| 22
| 33
| 0.730957
| 0.647949
| 3
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr after sadm
| 5
| 121
| 13.699219
| 63
| 32
| 39.29688
| 416.625
| 2
| 1.5
| 2
| 142
| 7.449219
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 897
| 1
|
64.81299
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 10
|
under $11k
| 0
| 12,726
| 8,069.832
| null | 16.5
|
white
| 30.199219
| 46
| 0.712891
| 0.554932
| 1
| 0
| 0
|
no
| 0.5
| 0.2
|
dnr after sadm
| 7
| 70
| 8.699219
| 60
| 20
| 35.59375
| 323.75
| null | null | 5.199219
| 125
| 7.259766
| null | null | null | 2
| null |
<2 mo. follow-up
| 1.839
| 29
| 1
|
82.15698
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 40,355
| 18,819.2812
| null | 20
|
white
| 23.097656
| 50
| 0.758911
| 0.681885
| 1
| 1
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 6
| 59
| 5.399414
| 60
| 26
| 37.69531
| 276.625
| 3.699707
| null | 2.199707
| 142
| 7.449219
| null | null | null | 4
| 6
|
adl>=4 (>=5 if sur)
| 6
| 116
| 1
|
83.16199
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 19
| null | 0
| 13,316
| 8,379.6406
| null | 57
|
white
| 42.398438
| 65
| 0.256958
| 0.151978
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 43
| 9.5
| 120
| 38
| 38.39844
| 123.32812
| 4.099609
| 1.099854
| 2.599609
| 141
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 2.83252
| 4
| 1
|
68.19995
|
female
| 0
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
>$50k
| 0
| 83,351
| 57,514.5
| null | 32.5
|
white
| 38.09375
| 63
| 0.487976
| 0.369995
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 43
| 49
| 8.398438
| 145
| 10
| 38.59375
| 105
| 3.299805
| 0.699951
| 3.299805
| 137
| 7.369141
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.031738
| 1,652
| 0
|
47.58899
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$25-$50k
| 0
| 6,175
| 4,326.5781
| null | 9
|
white
| 20.199219
| 19
| 0.848999
| 0.750977
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 7
| 80
| 5.299805
| 80
| 20
| 37
| null | null | 5
| 0.799927
| 131
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 190
| 1
|
74.05896
|
female
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 9,658
| 6,682.3438
| null | 8
|
white
| 29.398438
| 40
| 0.542969
| 0.219971
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.3
|
no dnr
| 10
| 100
| 6.799805
| 80
| 20
| 36.09375
| null | 2.699707
| 2.799805
| 10.398438
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,650
| 0
|
64.83496
|
female
| 1
| 9
|
Coma
|
Coma
| 0
| 18
|
$11-$25k
| 89
| 14,380
| 5,589.5703
| null | 12.5
|
asian
| 19.699219
| 23
| 0.387939
| 0.314941
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 56
| 9.798828
| 47
| 6
| 38.09375
| 393.3125
| 2.599609
| null | 0.799927
| 136
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 9
| 1
|
34.51297
|
male
| 0
| 61
|
Coma
|
Coma
| 2
| 12
| null | 0
| 123,827
| 33,595.5938
| null | 23
|
white
| 28.5
| 51
| 0.690918
| 0.636963
| 7
| 0
| 0
|
yes
| 1
| 1
|
no dnr
| 61
| 57
| 2
| 58
| 12
| 33.5
| 178
| 2.299805
| null | 1.399902
| 142
| 7.40918
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 1,232
| 1
|
85.54999
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 26
| 11,059
| 8,758.3984
| null | 11
|
white
| 26.796875
| 39
| 0.553955
| 0.356995
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 1
| 63
| 8.599609
| 66
| 24
| 35.59375
| 319
| null | null | 3.199707
| 129
| 7.449219
| null | null | null | null | null |
no(M2 and SIP pres)
| 4.527344
| 105
| 1
|
75.10999
|
male
| 0
| 17
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 17,967
| 12,273.4141
| null | 8.333328
|
white
| 24.898438
| 24
| 0.651978
| 0.346985
| 1
| 0
| 0
|
metastatic
| 1
| 0.6
|
no dnr
| 17
| 80
| 5.299805
| 60
| 25
| 38.89844
| null | 2.899902
| 1
| 1.299805
| 132
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,645
| 0
|
70.25098
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 21,914
| 15,529.125
| null | 28
|
white
| 26.898438
| 36
| 0.678955
| 0.508911
| 1
| 0
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 10
| 57
| 17.5
| 117
| 8
| 38.29688
| 125
| null | null | 1.199951
| 139
| 7.469727
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,642
| 0
|
80.35895
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 6,528
| 4,329.5859
| null | 12
|
white
| 16.097656
| 35
| 0.823975
| 0.713989
| 1
| 0
| 0
|
yes
| 1
| 0.9
|
no dnr
| 6
| 70
| 4.299805
| 80
| 35
| 37
| 211.09375
| null | null | 1.099854
| 140
| 7.40918
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,642
| 0
|
52.10397
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 18,313
| 8,718.0938
| null | 49
|
white
| 33
| 62
| 0.470947
| 0.35199
| 2
| 0
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 4
| 60
| 0.099991
| 120
| 8
| 36.59375
| 182.84375
| 2.199707
| null | 1.699951
| 138
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
83.461
|
male
| 1
| 87
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 20
|
$25-$50k
| 0
| 177,467
| 141,714.75
| null | 37.25
|
white
| 46.09375
| 71
| 0.158997
| 0.077988
| 1
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 87
| 43
| 3.199707
| 120
| 32
| 36.5
| 231.65625
| 2.199707
| 0.799927
| 2.899902
| 128
| 7.319336
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 87
| 1
|
75.33197
|
female
| 1
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 88,774
| 49,328.5625
| null | 18.25
|
white
| 28.398438
| 37
| 0.588989
| 0.480957
| 21
| 1
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 24
| 64
| 19.5
| 110
| 26
| 36.09375
| 253.03125
| null | 0.399963
| 1.399902
| 126
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 38
| 1
|
84.47894
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 12,504
| 8,726.3828
| null | 10.5
|
white
| 17.097656
| 29
| 0.750977
| 0.606934
| 1
| 0
| 0
|
yes
| 0.75
| 0.5
|
no dnr
| 11
| 105
| 10.199219
| 68
| 24
| 36.89844
| null | null | 0.5
| 1.799805
| 138
| 7.429688
| null | null | null | null | null |
no(M2 and SIP pres)
| 4.250977
| 1,637
| 0
|
85.48096
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 5,872
| 3,718.6934
| null | 8
|
white
| 17.097656
| 23
| 0.792969
| 0.666992
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 5
| 67
| 21.296875
| 70
| 20
| 36.69531
| 332
| null | null | 1.299805
| 144
| 7.339844
| null | null | null | 3
| null | null | 2.511099
| 1,096
| 1
|
64.06
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 4,562
| 3,148.3848
| null | 11
|
white
| 13
| 18
| 0.781982
| 0.542969
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 75
| 7.799805
| 100
| 18
| 36.89844
| null | 3.899902
| 0.399963
| 0.699951
| 134
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 93
| 1
|
55.896
|
female
| 1
| 33
|
Colon Cancer
|
Cancer
| 1
| 14
| null | 0
| 39,582
| 26,151.2344
| null | 14
| null | 7.799805
| 19
| 0.916992
| 0.806885
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.7
|
dnr before sadm
| 0
| 127
| 8.099609
| 60
| 22
| 37.69531
| null | 4.099609
| 0.399963
| 1.399902
| 139
| null | null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 33
| 1
|
65.29797
|
male
| 0
| 13
|
Colon Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 13,669
| 9,362.3203
| null | 13.5
|
white
| 16.5
| 12
| 0.823975
| 0.61792
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.15
|
dnr after sadm
| 5
| 60
| 12.298828
| 90
| 20
| 36.69531
| null | null | null | 0.799927
| 140
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 30
| 1
|
80.77496
|
female
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 0
| 82,763
| 62,808.2188
| null | 26.666656
|
white
| 23.796875
| 41
| 0.5979
| 0.490967
| 20
| 0
| 0
|
yes
| 0.2
| 0.05
|
dnr after sadm
| 4
| 53
| 18.597656
| 73
| 22
| 38.39844
| 383.3125
| null | 0.899902
| 7.399414
| 139
| 7.359375
| null | null | null | 6
| 6
|
<2 mo. follow-up
| 6
| 18
| 1
|
74.46698
|
female
| 1
| 36
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 9
| 46,365
| 32,123.8594
| null | 14
| null | 39.59375
| 54
| 0.122986
| 0.054993
| 2
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 3
| 47
| 3.399902
| 154
| 52
| 36.29688
| 284
| null | null | 0.599976
| 139
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 3.837402
| 36
| 1
|
74.875
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 18
|
under $11k
| 0
| 18,145
| 9,994.9297
| null | 10.333328
|
black
| 17
| 31
| 0.863892
| 0.816895
| 1
| 1
| 0
|
no
| 0.8
| 0.3
|
no dnr
| 15
| 62
| 7.099609
| 70
| 32
| 37.89844
| 620
| 4.199219
| null | 0.899902
| 154
| 7.379883
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 81
| 1
|
46.448
|
male
| 0
| 93
|
Coma
|
Coma
| 0
| null | null | 0
| 102,951
| 61,589.5312
| null | 32
|
white
| 43.398438
| 46
| 0.343994
| 0.270996
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 5
| 39
| 8.798828
| 130
| 8
| 34
| 162.5
| 2.599609
| null | 0.799927
| 144
| 7.379883
| null | null | null | null | null | null | 1.659912
| 1,629
| 0
|
36.36099
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 49,378
| 20,026.4531
| null | 27.666656
|
white
| 27.097656
| 49
| 0.819946
| 0.758911
| 6
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 19
| 57
| 8.5
| 100
| 34
| 39.29688
| 171.65625
| 2.299805
| 5
| 0.799927
| 148
| 7.439453
| null | null | null | 4
| 3
|
no(M2 and SIP pres)
| 3
| 1,631
| 0
|
84.758
|
female
| 0
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 55,554
| 41,568.0312
| null | 24
|
white
| 16.597656
| 32
| 0.753906
| 0.610962
| 8
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 1
| 70
| 5.799805
| 100
| 9
| 37.89844
| 343
| null | null | 1
| 132
| 7.449219
| null | null | null | null | null | null | 3.980957
| 201
| 1
|
73.09497
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 3,231
| 2,033.0977
| null | 9
|
white
| 8.898438
| 19
| 0.924927
| 0.872925
| 1
| 0
| 1
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 110
| 9.298828
| 60
| 20
| 37
| 324
| 4.399414
| 0.299988
| 1.099854
| 140
| 7.379883
| null | null | null | null | null | null | 4.662109
| 629
| 1
|
87.836
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 100
| 7,485
| 2,813.8379
| null | 21
|
white
| 20.796875
| 42
| 0.340942
| 0.224976
| 1
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 57
| 14.298828
| 111
| 14
| 37.89844
| 376.625
| 3.799805
| null | 1.199951
| 139
| 7.469727
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 3
| 1
|
65.21796
|
male
| 1
| 17
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 56,488
| 25,246.2031
| null | 45
|
white
| 42.796875
| 67
| 0.173981
| 0.047997
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 45
| 11.398438
| 120
| 8
| 37.69531
| 104
| 2.399902
| 1.899902
| 2.899902
| 136
| 7.339844
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
39.159
|
male
| 1
| 6
|
Lung Cancer
|
Cancer
| 2
| 14
|
$11-$25k
| 0
| 8,814
| 5,570.7383
| null | 27
|
white
| 48.59375
| 56
| 0.029999
| 0
| 1
| 0
| 0
|
metastatic
| 0.01
| 0.000001
|
dnr after sadm
| 3
| 52
| 31.097656
| 140
| 28
| 38.19531
| 121.65625
| 1.899902
| 0.5
| 0.599976
| 139
| 7.449219
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 6
| 1
|
61.23999
|
female
| 1
| 28
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 104,725
| 64,707.5
| null | 48.75
|
black
| 15.798828
| 21
| 0.820923
| 0.708984
| 3
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 28
| 129
| 6.799805
| 70
| 16
| 36.09375
| null | 2.199707
| null | 0.799927
| 143
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
85.05396
|
male
| 0
| 156
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 44
| 143,520
| 94,672.4375
| null | 20
|
white
| 31.296875
| 57
| 0.340942
| 0.224976
| 1
| 1
| 1
|
no
| 0.65
| 0.5
|
dnr after sadm
| 1
| 50
| 6.599609
| 48
| 37
| 38.09375
| 237.5
| null | null | 3
| 144
| 7.30957
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 420
| 1
|
80.54999
|
female
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
| null | 0
| 51,714
| 39,208.5
| null | 20.5
|
white
| 26.097656
| 53
| 0.633911
| 0.531982
| 10
| 1
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 1
| 63
| null | 39
| 28
| 36.09375
| null | null | null | 2.099609
| 134
| null | null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 59
| 1
|
73.30298
|
male
| 1
| 45
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 73,250
| 31,503.1719
| null | 22.75
|
white
| 25
| 43
| 0.689941
| 0.522949
| 1
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 32
| 57
| 9.099609
| 132
| 38
| 36.5
| 250
| null | null | 0.699951
| 137
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 2.676758
| 45
| 1
|
66.89899
|
female
| 1
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
| null | 37
| 87,649
| 76,678.5625
| null | 39.75
|
white
| 31.199219
| 52
| 0.478943
| 0.360962
| 2
| 1
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 33
| 130
| 11.898438
| 110
| 24
| 39.09375
| 138
| null | null | 3
| 145
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 33
| 1
|
62.04498
|
male
| 0
| 23
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 102,951
| 18,028.2969
| null | 18.666656
|
white
| 18.796875
| 39
| 0.881958
| 0.802979
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 23
| 77
| 9.199219
| 80
| 25
| 36.69531
| 203.3125
| 3.199707
| 0.799927
| 1.199951
| 135
| 7.469727
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,621
| 0
|
91.00098
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 25,116
| 12,177.7344
| null | 40
|
white
| 46.398438
| 53
| 0.051994
| 0.016998
| 12
| 0
| 0
|
no
| 0.3
| 0.15
|
dnr after sadm
| 2
| 41
| 17.796875
| 67
| 27
| 35.69531
| 320
| null | null | 2.799805
| 121
| 7.469727
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 7
| 1
|
70.86694
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 20,128
| 14,848.0938
| null | 26
|
white
| 24.5
| 22
| 0.778931
| 0.706909
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 13
| 57
| 10.599609
| 52
| 22
| 39.29688
| 171.40625
| 2.5
| 1.899902
| 0.799927
| 139
| 7.439453
| null | null | null | 0
| null | null | 0.4948
| 1,269
| 1
|
80.80798
|
male
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 21,600
| 16,596.6094
| null | 42.5
|
white
| 47.398438
| 90
| 0.058998
| 0.019997
| 2
| 0
| 0
|
yes
| 0.04
| 0.000064
|
dnr after sadm
| 6
| 40
| 99
| 174
| 48
| 36.29688
| 95
| 2.099609
| null | 1.399902
| 146
| 7.469727
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
39.01398
|
male
| 0
| 54
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 143,863
| 52,669.7188
| null | 39.5
|
white
| 46.695313
| 75
| 0.440979
| 0.32196
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 54
| 47
| 12.5
| 120
| 46
| 36.59375
| 145
| 2.799805
| 4.699219
| 6.199219
| 134
| 7.40918
| null | null | null | null | 0
| null | 0
| 1,619
| 0
|
96.29297
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 23,315
| 14,476.0781
| null | 31
|
white
| 25.898438
| 35
| 0.557983
| 0.445984
| 1
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 11
| 115
| 3.599609
| 59
| 24
| 37.69531
| 409.5
| 3.199707
| null | 3.899902
| 138
| 7.379883
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 327
| 1
|
60.96399
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 7,831
| 5,228.7148
| null | 7
|
white
| 17
| 15
| 0.897949
| 0.829956
| 1
| 1
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 7
| 60
| 10.699219
| 60
| 20
| 36.69531
| 360
| null | null | 1.199951
| 135
| 7.399414
| null | null | null | 4
| null |
SIP>=30
| 3.183199
| 1,616
| 0
|
57.892
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 3,803
| 2,349.0977
| null | 12
|
black
| 17.097656
| 21
| 0.721924
| 0.445984
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 4
| 71
| 4.799805
| 110
| 24
| 37.09375
| 266.625
| null | null | 1.099854
| 139
| 7.489258
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 152
| 1
|
79.43097
|
female
| 0
| 46
|
Colon Cancer
|
Cancer
| 2
| 19
|
$11-$25k
| 0
| 41,940
| 31,571.2969
| null | 3.25
|
white
| 28.097656
| 17
| 0.55896
| 0.235992
| 1
| 1
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 87
| 5.299805
| 109
| 20
| 36.09375
| null | 2.899902
| 1
| 0.899902
| 131
| null | null | null | null | 0
| 5
| null | 5
| 60
| 1
|
84.25494
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 4,931
| 3,273.2148
| null | 9
|
white
| 17.796875
| 24
| 0.826904
| 0.717896
| 1
| 0
| 0
|
no
| 0.98
| 0.8
|
no dnr
| 5
| 73
| 9.599609
| 80
| 20
| 36.69531
| 392
| null | null | 1.899902
| 135
| 7.459961
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,578
| 1
|
62.97897
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 42,691
| 24,151.6406
| null | 11.5
|
black
| 23
| 18
| 0.783936
| 0.654907
| 19
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 9
| 125
| 14.699219
| 119
| 24
| 36.29688
| 292
| null | null | 0.599976
| 139
| 7.419922
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,606
| 0
|
75.34296
|
male
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 15,764
| 10,021.3438
| null | 12
|
white
| 11.298828
| 27
| 0.866943
| 0.701904
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.125
|
no dnr
| 12
| 67
| 9.599609
| 80
| 20
| 40
| null | 3.799805
| null | 1.099854
| 138
| null | null | null | null | 1
| 1
| null | 1
| 60
| 1
|
65.20697
|
female
| 0
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 0
| 27,314
| 13,883.3828
| null | 31
|
white
| 45.5
| 61
| 0.125977
| 0.056999
| 1
| 0
| 0
|
yes
| 0.6
| 0.1
|
dnr after sadm
| 2
| 40
| 0.299988
| 180
| 22
| 35.59375
| 381.625
| 4
| 0.899902
| 0.699951
| 135
| 7.419922
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 28
| 1
|
75.45197
|
male
| 1
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$25-$50k
| 0
| 27,479
| 20,806.5469
| null | 19.666656
|
white
| 33.695313
| 68
| 0.564941
| 0.369995
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 20
| 44
| 8.699219
| 64
| 26
| 35.59375
| 276.1875
| null | 0.599976
| 2.599609
| 137
| 7.569336
| null | null | null | 0
| 2
|
<2 mo. follow-up
| 2
| 24
| 1
|
74.17096
|
female
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 24,406
| 16,957.9062
| null | 43
|
white
| 16.796875
| 14
| 0.844971
| 0.791992
| 4
| 0
| 0
|
no
| 0.3
| 0.2
|
no dnr
| 5
| 66
| 7.399414
| 60
| 10
| 38.79688
| 180
| 2.799805
| null | 1
| 143
| 7.40918
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,604
| 0
|
55.31799
|
female
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 91,472
| 62,769.8438
| null | 41.333313
|
white
| 27.296875
| 33
| 0.753906
| 0.675903
| 5
| 0
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 21
| 66
| 15
| 51
| 10
| 39.09375
| 161.65625
| null | 1.5
| 2.299805
| 141
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 21
| 1
|
61.06998
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 37,517
| 25,528.4062
| null | 29
|
white
| 24.597656
| 29
| 0.796997
| 0.67395
| 5
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 10
| 67
| 12.898438
| 70
| 10
| 36.39844
| 118
| null | null | 0.599976
| 142
| 7.489258
| null | null | null | 0
| null | null | 0.4948
| 1,599
| 0
|
76.57996
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 0
| 46,322
| 35,720.125
| null | 26
|
white
| 37.695313
| 69
| 0.290955
| 0.181
| 4
| 0
| 0
|
yes
| 0.4
| 0.1
|
no dnr
| 17
| 56
| 15.298828
| 110
| 12
| 38.29688
| 170
| 2.899902
| 13.898438
| 3.099609
| 137
| 7.379883
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 44
| 1
|
91.47198
|
female
| 0
| 25
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 17
|
>$50k
| 9
| 58,579
| 34,724.0312
| null | 22.333328
|
white
| 33
| 50
| 0.270996
| 0.163971
| 10
| 0
| 0
|
yes
| 0.3
| 0.2
|
dnr after sadm
| 9
| 53
| 1.599854
| 120
| 26
| 36.19531
| 390
| null | null | 1
| 138
| 7.5
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 71
| 1
|
22.31099
|
male
| 0
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 44
| 69,109
| 56,255.5
| null | 17
|
white
| 19.097656
| 15
| 0.868896
| 0.822998
| 4
| 0
| 0
|
no
| 0.2
| 0.5
|
no dnr
| 53
| 110
| 9.298828
| 120
| 10
| 39
| 434.6875
| null | null | 0.899902
| 135
| 7.449219
| null | null | null | null | 1
| null | 1
| 1,596
| 0
|
60.40799
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 0
| 26,252
| 17,970.7188
| null | 28
|
white
| 17
| 10
| 0.894897
| 0.856934
| 1
| 0
| 0
|
no
| 0.85
| 0.6
|
no dnr
| 11
| 63
| 11
| 96
| 12
| 37.89844
| 282.125
| 2.599609
| 0.899902
| 0.799927
| 138
| 7.359375
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,598
| 0
|
77.15497
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 84,411
| 47,659.9375
| null | 24
|
white
| 40.695313
| 59
| 0.21698
| 0.119995
| 33
| 0
| 0
|
no
| 0.5
| 0.125
|
no dnr
| 19
| 45
| 19.5
| 38
| 24
| 34.79688
| 200
| 2
| 1.899902
| 1.899902
| 146
| 7.489258
| null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 33
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.